NFKB1 and Alzheimer disease: Previous studies demonstrated the complex dynamics of the immune response during AD and a significant contribution to the exacerbation of neurodegeneration (8, 50–52) proposing the activation of the NF-κB pathway as one of the earliest inflammatory hallmarks in AD (53).